ESC Premium Access

Roundtable discussion: what can we learn from current guidelines – Do they accurately reflect current knowledge and what can we expect over time?

Congress Presentation

About the speakers

Doctor Eric Peterson

UT Southwestern Medical Center, Dallas (United States of America)
13 presentations
0 follower

Professor Lars Ryden

Karolinska Institute, Stockholm (Sweden)
33 presentations
0 follower

3 more presentations in this session

Opening remarks - A closer look at glucose lowering agents CV safety results and current heart failure guidelines.

Speaker: Doctor A. Gitt (Ludwigshafen, DE)

Thumbnail

Latest insights from the TECOS Trial: clarifying the role for dipeptidyl peptidase-4 (DPP-4) inhibitors in the treatment of cardiovascular patients with type 2 diabetes and heart failure.

Speaker: Doctor E. Peterson (Dallas, US)

Thumbnail

Closing remarks - A closer look at glucose lowering agents cardiovascular safety results and current heart failure guidelines.

Speaker: Doctor A. Gitt (Ludwigshafen, DE)

Thumbnail

Access the full session

A closer look at glucose lowering agents cardiovascular safety results and current heart failure guidelines

Speakers: Doctor E. Peterson, Professor L. Ryden, Doctor A. Gitt, Doctor E. Peterson, Doctor A. Gitt
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk